consider reducing doses of these medications when initiating tirzepatide Signs of acute kidney injury, particularly in patients experiencing severe gastrointestinal adverse effects with dehydration Symptoms of pancreatitis (severe abdominal pain radiating to the back, nausea, vomiting) Gallbladder disease (right upper quadrant pain, fever, jaundice) Gastrointestinal adverse effects, which occur commonly but are usually self-limited Tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis
A Study of RG7314 to Investigate Efficacy Safety in Individuals with Autism Spectrum Disorders (ASD) (2018)
What You Need to Know About Gastroparesis and GLP-1 Medications Lauren Barkley Feb 28, 2025 3 min read In August of 2023, a personal injury class-action lawsuit was initiated against Novo Nordisk regarding their GLP-1 agonist medications (King and Nigh, 2025)
Christensen, S., Robinson, K., Thomas, S., & Williams, D
Nat Commun 9:3533